Jacques Simard
Biographic Data
| ID | 4115927 |
|---|---|
| NAME | Jacques Simard |
| GIVEN NAMES | Jacques |
| FAMILY NAME | Simard |
| SIGNATURE | SIMARD J |
| AFFILIATIONS | Université Laval |
| ORCID | 0000-0001-6906-3390 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2006 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
General Medical Practitioners Acting as Geneticists, a Risky Business
The availability of precision medicine tools and approaches has increased considerably over the past decades, propelled by rapid scientific advances in genomics and the popularity of direct-to-consumer genetic testing. Genetic specialists working within public healthcare systems are struggling to meet the growing demand for clinical genetic services. Some experts have suggested that doctors who are not specialized in genetics could take on some o…
Survey of primary care physicians’ views about breast and ovarian cancer screening for true BRCA1/2 non-carriers
Organizational challenges to equity in the delivery of services within a new personalized risk-based approach to breast cancer screening
Emerging evidence opens new possibilities to improve current breast cancer mammography screening programs. One promising avenue is to tailor mammography screening according to individual risk. However, some factors could challenge the implementation of such approach, specifically its potential impact on the equitable delivery of services. This study aims to identify the barriers and facilitators to the equitable delivery of services within a futu…
Using the Impact of Event Scale to Evaluate Distress in the Context of Genetic Testing for Breast Cancer Susceptibility
The data obtained with two forms of the Impact of Event Scale were compared, one referring to a BRCA1/2 test result (IES-T) and another to cancer (IES-C). The sample consisted of 272 women with a family history suggestive of a BRCA1/2 mutation who underwent genetic testing and received results: noncarrier, carrier, or inconclusive. Globally, mean scores on the IES-C form were higher than those obtained on the IES-T form. Among carriers of a BRCA1…
No prominent works on this page.
Using the Impact of Event Scale to Evaluate Distress in the Context of Genetic Testing for Breast Cancer Susceptibility
The data obtained with two forms of the Impact of Event Scale were compared, one referring to a BRCA1/2 test result (IES-T) and another to cancer (IES-C). The sample consisted of 272 women with a family history suggestive of a BRCA1/2 mutation who underwent genetic testing and received results: noncarrier, carrier, or inconclusive. Globally, mean scores on the IES-C form were higher than those obtained on the IES-T form. Among carriers of a BRCA1…
Organizational challenges to equity in the delivery of services within a new personalized risk-based approach to breast cancer screening
Emerging evidence opens new possibilities to improve current breast cancer mammography screening programs. One promising avenue is to tailor mammography screening according to individual risk. However, some factors could challenge the implementation of such approach, specifically its potential impact on the equitable delivery of services. This study aims to identify the barriers and facilitators to the equitable delivery of services within a futu…
Survey of primary care physicians’ views about breast and ovarian cancer screening for true BRCA1/2 non-carriers
General Medical Practitioners Acting as Geneticists, a Risky Business
The availability of precision medicine tools and approaches has increased considerably over the past decades, propelled by rapid scientific advances in genomics and the popularity of direct-to-consumer genetic testing. Genetic specialists working within public healthcare systems are struggling to meet the growing demand for clinical genetic services. Some experts have suggested that doctors who are not specialized in genetics could take on some o…
BRCA gene mutations in cancer (3 works) · Breast cancer (3 works) · Cancer (3 works) · Medicine (3 works) · Psychology (3 works) · Business (2 works) · Global Cancer Incidence and Screening (2 works) · Internal Medicine (2 works) · Oncology (2 works) · Biology (1 works)